Featured image
Biotechnology Engineers

MiNA Therapeutics

MiNA Therapeutics is a biotechnology company based in London, England. They specialize in the development of therapeutic RNA medicines that activate and inhibit gene expression to treat a range of diseases. MiNA Therapeutics operates in the Translation & Innovation Hub and has a team of highly skilled biotechnology engineers. They also have expertise in IT & E-Commerce to support their research and development efforts.

Introduction to MiNA Therapeutics

MiNA Therapeutics is a biotechnology company based in London, England. The company was founded in 2008 with the purpose of developing novel medicines based on RNA activation. MiNA Therapeutics is unique in its approach to drug development, using a proprietary platform technology to develop small activating RNA molecules (saRNAs) to modulate gene expression and treat diseases. The company's team is made up of experienced biotechnology engineers and IT & E-commerce professionals who are dedicated to developing innovative treatments for patients.

Services & products

MiNA Therapeutics offers a range of services related to drug development. The company's proprietary platform technology enables the development of saRNAs for the treatment of various diseases, including cancer, liver diseases, and genetic disorders. MiNA Therapeutics also collaborates with other companies and academic institutions to develop new therapies.

Location

MiNA Therapeutics is located in the Translation & Innovation Hub on Wood Lane in London. The area is known for its vibrant mix of businesses, including media companies, tech startups, and research institutions. The Translation & Innovation Hub is conveniently located near several public transportation options, including the White City and Wood Lane tube stations, as well as the Shepherd's Bush overground station.

Benefits

Customers should choose MiNA Therapeutics because of the company's unique approach to drug development. By using saRNAs to modulate gene expression, MiNA Therapeutics is able to develop effective treatments for diseases that were previously untreatable. The company's team of experienced professionals is dedicated to developing innovative therapies that will improve the lives of patients around the world.

Good to know

Customers should be aware that MiNA Therapeutics is a biotechnology company focused on drug development, and does not offer medical services directly to patients. The company's saRNA therapies are still in the early stages of development and have not yet been approved for use by regulatory agencies.

Reviews

MiNA Therapeutics has received positive reviews from customers and partners in the biotechnology industry. Customers praise the company's innovative approach to drug development and its team of experienced professionals. Partners appreciate the company's collaborative approach to research and development, which has led to several successful partnerships and collaborations.

Amenities

  • amenity
    laboratory
  • amenity
    equipment
  • amenity
    software
  • amenity
    automation
  • amenity
    data analysis
  • amenity
    research
  • amenity
    development
  • amenity
    testing

FAQ

What kind of biotechnology projects have you successfully completed in the past?

We have successfully completed a range of biotechnology projects, including the development of novel RNA therapeutics for the treatment of liver cancer and the creation of a platform for the targeted delivery of RNA to specific cell types.

How do you ensure the confidentiality of our proprietary information during the development process?

We take confidentiality very seriously and ensure that all employees and contractors sign non-disclosure agreements before starting work with us. We also have strict policies and procedures in place to safeguard any proprietary information that we may be given access to during the development process.

What regulatory requirements do you take into consideration when developing biotechnology products?

We take all relevant regulatory requirements into consideration when developing biotechnology products, including those related to safety, efficacy, and quality. We work closely with regulatory authorities to ensure that our products meet all necessary standards and requirements.

Can you provide examples of how you have collaborated with other companies or research institutions to develop biotechnology products?

Yes, we have collaborated with a range of companies and research institutions to develop biotechnology products. For example, we have worked with academic researchers to develop new RNA delivery technologies, and we have partnered with pharmaceutical companies to develop RNA therapeutics for various diseases.

How do you stay current with emerging technologies in the biotechnology field?

We stay current with emerging technologies in the biotechnology field by actively participating in industry conferences and events, reading scientific journals and publications, and collaborating with other researchers and companies in the field. We also have a dedicated team of researchers who are constantly exploring new technologies and approaches to biotechnology.